PE20181924A1 - Inhibidores de la arginasa y sus aplicaciones terapeuticas - Google Patents
Inhibidores de la arginasa y sus aplicaciones terapeuticasInfo
- Publication number
- PE20181924A1 PE20181924A1 PE2018002300A PE2018002300A PE20181924A1 PE 20181924 A1 PE20181924 A1 PE 20181924A1 PE 2018002300 A PE2018002300 A PE 2018002300A PE 2018002300 A PE2018002300 A PE 2018002300A PE 20181924 A1 PE20181924 A1 PE 20181924A1
- Authority
- PE
- Peru
- Prior art keywords
- boronoethyl
- amino
- linear
- arginase
- branched
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 102000004452 Arginase Human genes 0.000 title 1
- 108700024123 Arginases Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- HXBUDPSAWAKGEG-UHFFFAOYSA-N 1-amino-3-(2-boronoethyl)-2-methylcyclopentane-1-carboxylic acid Chemical compound NC1(C(C(CC1)CCB(O)O)C)C(=O)O HXBUDPSAWAKGEG-UHFFFAOYSA-N 0.000 abstract 1
- SMLPIZSADMHXPG-UHFFFAOYSA-N 1-amino-3-(2-boronoethyl)cyclopentane-1-carboxylic acid Chemical compound NC1(CC(CC1)CCB(O)O)C(=O)O SMLPIZSADMHXPG-UHFFFAOYSA-N 0.000 abstract 1
- -1 3- (boronoethyl) cyclopentane-1-carboxylic Chemical compound 0.000 abstract 1
- 102100021723 Arginase-1 Human genes 0.000 abstract 1
- 101710129000 Arginase-1 Proteins 0.000 abstract 1
- 102100030356 Arginase-2, mitochondrial Human genes 0.000 abstract 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 abstract 1
- 101000792835 Homo sapiens Arginase-2, mitochondrial Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229910052796 boron Inorganic materials 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000000686 lactone group Chemical group 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 150000003384 small molecules Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se refiere a un compuesto de formula i en donde l es CO2H, -C(O)O(alquilo(C1-C6), entre otros; R1 puede ser H, alquilo (C1-C6) lineal o ramificado, entre otros X, Y, Z pueden ser -C(R´)(R´´)-, -C(R´´)2, entre otros; Z y L forman opcionalmente un anillo de lactona fusionado que tiene de 4 a 7 atomos miembros del anillo; m, n, p son enteros entre 0 y 2; R2 Y R3 tomados junto con el atomo de boro y oxigeno forman un anillo de 4, 5, 6 o 7 miembros; v puede ser -C(R´)(R´´)-, -NR´, entre otros; W puede ser -C(R´)(R´´´)-; D puede ser alquileno (C1-C5) lineal o ramificado, alquenileno(C2-C8) lineal o ramificado. Son compuestos preferidos acido 1-amino-3-(2-boronoetil)ciclopentano-1-carboxilico, acido 1-amino-3-(2-boronoetil)-2-metilciclopentano-1-carboxilico, clorhidrato del acido 1-amino-3-(boronoetil)ciclopentano-1-carboxilico. Dichos compuestos terapeuticos de moleculas pequenas son potentes inhibidores de la actividad de la Arginasa 1 y Arginasa 2. Tambien se refiere a una composicion farmaceutica y un metodo de tratamiento que son utiles en el tratamiento del cancer.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662331550P | 2016-05-04 | 2016-05-04 | |
PL417066A PL417066A1 (pl) | 2016-05-04 | 2016-05-04 | Inhibitory arginazy oraz ich zastosowania terapeutyczne |
US201762444669P | 2017-01-10 | 2017-01-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20181924A1 true PE20181924A1 (es) | 2018-12-11 |
Family
ID=60190450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2018002300A PE20181924A1 (es) | 2016-05-04 | 2017-05-02 | Inhibidores de la arginasa y sus aplicaciones terapeuticas |
Country Status (24)
Country | Link |
---|---|
US (3) | US10391077B2 (es) |
EP (1) | EP3452485B1 (es) |
JP (1) | JP6971477B2 (es) |
KR (1) | KR102374788B1 (es) |
CN (1) | CN109415387B (es) |
AU (1) | AU2017259887B2 (es) |
BR (1) | BR112018072545B1 (es) |
CA (1) | CA3022482A1 (es) |
CL (1) | CL2018003132A1 (es) |
CO (1) | CO2018013077A2 (es) |
DK (1) | DK3452485T3 (es) |
ES (1) | ES2834065T3 (es) |
HR (1) | HRP20201821T1 (es) |
HU (1) | HUE052468T2 (es) |
IL (1) | IL262387B (es) |
LT (1) | LT3452485T (es) |
MX (1) | MX2018013387A (es) |
PE (1) | PE20181924A1 (es) |
PH (1) | PH12018501976A1 (es) |
PL (2) | PL417066A1 (es) |
SA (1) | SA518400356B1 (es) |
SG (1) | SG11201807974QA (es) |
SI (1) | SI3452485T1 (es) |
WO (1) | WO2017191130A2 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2632927T3 (en) | 2010-10-26 | 2016-04-11 | Mars Inc | Boronates AS ARGINSASEINHIBITORER |
US10070649B2 (en) | 2013-01-30 | 2018-09-11 | Agrofresh Inc. | Volatile applications against pathogens |
US11039617B2 (en) | 2013-01-30 | 2021-06-22 | Agrofresh Inc. | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
CN108271371B (zh) | 2015-10-30 | 2021-02-09 | 卡里塞拉生物科学股份公司 | 用于抑制精氨酸酶活性的组合物和方法 |
RS64770B1 (sr) | 2016-03-07 | 2023-11-30 | Agrofresh Inc | Sinergistički postupci upotrebe jedinjenja benzoksaborola i gasova za prezerviranje kao antimikrobnih agenasa za useve |
PL417066A1 (pl) * | 2016-05-04 | 2017-11-06 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Inhibitory arginazy oraz ich zastosowania terapeutyczne |
SG11202007739XA (en) | 2018-02-17 | 2020-09-29 | Astrazeneca Ab | Arginase inhibitors and methods of use thereof |
US20210002306A1 (en) * | 2018-03-05 | 2021-01-07 | Arcus Biosciences, Inc. | Arginase inhibitors |
EP3765006A4 (en) * | 2018-03-13 | 2022-02-23 | Merck Sharp & Dohme Corp. | ARGINASE INHIBITORS AND METHODS OF USE |
US10851099B2 (en) | 2018-03-29 | 2020-12-01 | Oncoarendi Therapeutics S.A. | Dipeptide piperidine derivatives |
WO2019245890A1 (en) * | 2018-06-20 | 2019-12-26 | Merck Sharp & Dohme Corp. | Arginase inhibitors and methods of use |
WO2020131598A1 (en) * | 2018-12-18 | 2020-06-25 | Merck Sharp & Dohme Corp. | Arginase inhibitors and methods of use |
WO2021141751A1 (en) * | 2020-01-07 | 2021-07-15 | Merck Sharp & Dohme Corp. | Arginase inhibitors and methods of use |
TW202228720A (zh) * | 2020-12-22 | 2022-08-01 | 波蘭商昂科艾倫迪治療法股份公司 | 精胺酸酶抑制劑及其使用方法 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2082951C (en) | 1991-03-15 | 1999-12-21 | Robert M. Platz | Pulmonary administration of granulocyte colony stimulating factor |
US5451569A (en) | 1994-04-19 | 1995-09-19 | Hong Kong University Of Science And Technology R & D Corporation Limited | Pulmonary drug delivery system |
CA2305703A1 (en) | 1997-10-10 | 1999-04-22 | David W. Christianson | Compositions and methods for inhibiting arginase activity |
EP1604977A1 (en) | 2004-06-02 | 2005-12-14 | Faust Pharmaceuticals | CIS pyrrolidinyl derivatives and their uses |
EP1604978A1 (en) | 2004-06-02 | 2005-12-14 | Faust Pharmaceuticals | Trans pyrrolidinyl derivatives and their pharmaceutical uses |
MX2009005370A (es) | 2006-11-21 | 2009-10-16 | Univ Groningen | Uso de inhibidores de arginasa en el tratamiento de asma y rinitis alergica. |
EP2389352B1 (en) | 2009-01-26 | 2019-05-08 | The Trustees Of The University Of Pennsylvania | Arginase inhibitors and methods of use |
NZ603364A (en) | 2010-04-22 | 2015-06-26 | Mars Inc | Inhibitors of arginase and their therapeutic applications |
WO2012025155A1 (en) | 2010-08-26 | 2012-03-01 | Novartis Ag | Hydroxamate-based inhibitors of deacetylases |
DK2632927T3 (en) | 2010-10-26 | 2016-04-11 | Mars Inc | Boronates AS ARGINSASEINHIBITORER |
WO2012091757A1 (en) | 2010-12-31 | 2012-07-05 | Corridor Pharmaceuticals, Inc. | Arginase inhibitors and methods of use thereof |
WO2013059437A1 (en) | 2011-10-19 | 2013-04-25 | Mars, Incorporated | Inhibitors of arginase and their therapeutic applications |
BR112014026057B1 (pt) | 2012-04-18 | 2020-10-13 | Mars, Incorporated | composto inibidor da arginase, composição farmacêutica e uso do composto |
HUE030685T2 (en) | 2012-07-13 | 2017-05-29 | Janssen Sciences Ireland Uc | Macrocyclic purines for treating viral infections |
PL410665A1 (pl) | 2014-12-29 | 2016-07-04 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Inhibitory arginazy oraz ich zastosowania terapeutyczne |
JP2018520352A (ja) | 2015-06-23 | 2018-07-26 | カリセラ バイオサイエンシズ,インコーポレイテッド | アルギナーゼ活性を阻害するための組成物および方法 |
CN108271371B (zh) | 2015-10-30 | 2021-02-09 | 卡里塞拉生物科学股份公司 | 用于抑制精氨酸酶活性的组合物和方法 |
PL417066A1 (pl) * | 2016-05-04 | 2017-11-06 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Inhibitory arginazy oraz ich zastosowania terapeutyczne |
MA46793A (fr) | 2016-11-08 | 2019-09-18 | Calithera Biosciences Inc | Polythérapies faisant appel à un inhibiteur d'arginase |
CN111902532A (zh) | 2018-01-28 | 2020-11-06 | 日内瓦大学 | 用于癌症治疗的精氨酸酶抑制 |
-
2016
- 2016-05-04 PL PL417066A patent/PL417066A1/pl unknown
-
2017
- 2017-05-02 HU HUE17721137A patent/HUE052468T2/hu unknown
- 2017-05-02 BR BR112018072545-5A patent/BR112018072545B1/pt active IP Right Grant
- 2017-05-02 US US15/584,193 patent/US10391077B2/en active Active
- 2017-05-02 CN CN201780041841.9A patent/CN109415387B/zh active Active
- 2017-05-02 AU AU2017259887A patent/AU2017259887B2/en active Active
- 2017-05-02 JP JP2018556824A patent/JP6971477B2/ja active Active
- 2017-05-02 SI SI201730505T patent/SI3452485T1/sl unknown
- 2017-05-02 WO PCT/EP2017/060413 patent/WO2017191130A2/en active Application Filing
- 2017-05-02 SG SG11201807974QA patent/SG11201807974QA/en unknown
- 2017-05-02 PE PE2018002300A patent/PE20181924A1/es unknown
- 2017-05-02 PL PL17721137T patent/PL3452485T3/pl unknown
- 2017-05-02 ES ES17721137T patent/ES2834065T3/es active Active
- 2017-05-02 KR KR1020187034423A patent/KR102374788B1/ko active IP Right Grant
- 2017-05-02 MX MX2018013387A patent/MX2018013387A/es unknown
- 2017-05-02 CA CA3022482A patent/CA3022482A1/en active Pending
- 2017-05-02 DK DK17721137.2T patent/DK3452485T3/da active
- 2017-05-02 EP EP17721137.2A patent/EP3452485B1/en active Active
- 2017-05-02 LT LTEP17721137.2T patent/LT3452485T/lt unknown
-
2018
- 2018-09-13 PH PH12018501976A patent/PH12018501976A1/en unknown
- 2018-10-15 IL IL262387A patent/IL262387B/en unknown
- 2018-11-01 SA SA518400356A patent/SA518400356B1/ar unknown
- 2018-11-05 CL CL2018003132A patent/CL2018003132A1/es unknown
- 2018-12-03 CO CONC2018/0013077A patent/CO2018013077A2/es unknown
-
2019
- 2019-08-14 US US16/540,747 patent/US10912755B2/en active Active
-
2020
- 2020-11-16 HR HRP20201821TT patent/HRP20201821T1/hr unknown
-
2021
- 2021-02-05 US US17/168,291 patent/US20210260019A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20181924A1 (es) | Inhibidores de la arginasa y sus aplicaciones terapeuticas | |
PE20191541A1 (es) | Composiciones y metodos para inhibir la accion de la arginasa | |
AR120700A1 (es) | Inhibidores de kras g12c | |
PE20142098A1 (es) | Compuestos terapeuticamente activos y sus metodos de uso | |
AR107694A1 (es) | Heteroarilos inhibidores de pad4 | |
AR086254A1 (es) | Derivados de imidazol utiles para el tratamiento de artritis | |
EA201890450A1 (ru) | Циклические динуклеотидные соединения в качестве агонистов sting | |
PE20191540A1 (es) | DERIVADOS DE PIRROLO [1,2-b] PIRIDAZINA | |
PE20180040A1 (es) | Derivados de 2-(feniloxi o feniltio)pirimidina como herbicidas | |
PE20180024A1 (es) | Triazolopirazinonas como inhibidores de pde1 | |
AR078152A1 (es) | Compuestos heterociclicos, utiles para el tratamiento de hcv y composiciones farmaceuticas que los comprenden | |
PE20191020A1 (es) | Compuestos quimicos | |
ES2631611T3 (es) | Amidas de piperidina de Pirano-Espirociclico como moduladores de canales iónicos | |
AR078278A1 (es) | Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro. | |
PE20191142A1 (es) | 2,4 diamino-quinolina sustituida como nuevos agentes anti-cancerigenos | |
AR077080A1 (es) | Compuestos de 2,3-dihidro-1h-indeno | |
PE20210478A1 (es) | Compuestos heteroaromaticos como inhibidores de vanina | |
CO2019004978A2 (es) | Compuestos terapéuticos y métodos para utilizarlos | |
CO2019002517A2 (es) | Inhibidores de dopamina–β–hidroxilasa | |
PE20171335A1 (es) | Inhibidores de gingipaina de lisina | |
CO2017003969A2 (es) | Derivado de isoxazol como inhibidor de isocitrato deshidrogenasa 1 mutante | |
CO2018010787A2 (es) | Compuesto de griseofulvina | |
AR043444A1 (es) | Profarmacos de diaril-2- 5h -furanonas que liberan oxido nitrico como inhibidores de la ciclooxigenasa-2 | |
PE20190376A1 (es) | Combinaciones farmaceuticas para el tratamiento del cancer | |
EA201791671A1 (ru) | 4-замещенные соединения бензоксаборола и их применение |